These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 36208084)
1. GPR109a Regulates Phenotypic and Functional Alterations in Macrophages and the Progression of Type 1 Diabetes. Zhang Z; Li J; Zhang M; Li B; Pan X; Dong X; Pan LL; Sun J Mol Nutr Food Res; 2022 Dec; 66(23):e2200300. PubMed ID: 36208084 [TBL] [Abstract][Full Text] [Related]
2. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Singh N; Gurav A; Sivaprakasam S; Brady E; Padia R; Shi H; Thangaraju M; Prasad PD; Manicassamy S; Munn DH; Lee JR; Offermanns S; Ganapathy V Immunity; 2014 Jan; 40(1):128-39. PubMed ID: 24412617 [TBL] [Abstract][Full Text] [Related]
4. Exploring the role of the metabolite-sensing receptor GPR109a in diabetic nephropathy. Snelson M; Tan SM; Higgins GC; Lindblom RSJ; Coughlan MT Am J Physiol Renal Physiol; 2020 Mar; 318(3):F835-F842. PubMed ID: 32068460 [TBL] [Abstract][Full Text] [Related]
5. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. Lukasova M; Malaval C; Gille A; Kero J; Offermanns S J Clin Invest; 2011 Mar; 121(3):1163-73. PubMed ID: 21317532 [TBL] [Abstract][Full Text] [Related]
6. GPR41 deficiency aggravates type 1 diabetes in streptozotocin-treated mice by promoting dendritic cell maturation. Li JH; Zhang M; Zhang ZD; Pan XH; Pan LL; Sun J Acta Pharmacol Sin; 2024 Jul; 45(7):1466-1476. PubMed ID: 38514862 [TBL] [Abstract][Full Text] [Related]
7. Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential. Gaidarov I; Chen X; Anthony T; Maciejewski-Lenoir D; Liaw C; Unett DJ Cell Signal; 2013 Oct; 25(10):2003-16. PubMed ID: 23770183 [TBL] [Abstract][Full Text] [Related]
8. A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages. Bauset C; Carda-Diéguez M; Cejudo-Garcés A; Buetas E; Seco-Cervera M; Macias-Ceja DC; Navarro-Vicente F; Esplugues JV; Calatayud S; Mira Á; Ortiz-Masiá D; Barrachina MD; Cosín-Roger J Biochim Biophys Acta Mol Basis Dis; 2024 Dec; 1870(8):167489. PubMed ID: 39233260 [TBL] [Abstract][Full Text] [Related]
9. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms. Felizardo RJF; de Almeida DC; Pereira RL; Watanabe IKM; Doimo NTS; Ribeiro WR; Cenedeze MA; Hiyane MI; Amano MT; Braga TT; Ferreira CM; Parmigiani RB; Andrade-Oliveira V; Volpini RA; Vinolo MAR; Mariño E; Robert R; Mackay CR; Camara NOS FASEB J; 2019 Nov; 33(11):11894-11908. PubMed ID: 31366236 [TBL] [Abstract][Full Text] [Related]
10. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy. Gambhir D; Ananth S; Veeranan-Karmegam R; Elangovan S; Hester S; Jennings E; Offermanns S; Nussbaum JJ; Smith SB; Thangaraju M; Ganapathy V; Martin PM Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2208-17. PubMed ID: 22427566 [TBL] [Abstract][Full Text] [Related]
11. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets. Chen L; So WY; Li SY; Cheng Q; Boucher BJ; Leung PS Mol Cell Endocrinol; 2015 Mar; 404():56-66. PubMed ID: 25622782 [TBL] [Abstract][Full Text] [Related]
12. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Thangaraju M; Cresci GA; Liu K; Ananth S; Gnanaprakasam JP; Browning DD; Mellinger JD; Smith SB; Digby GJ; Lambert NA; Prasad PD; Ganapathy V Cancer Res; 2009 Apr; 69(7):2826-32. PubMed ID: 19276343 [TBL] [Abstract][Full Text] [Related]
13. Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells. Wang N; Guo DY; Tian X; Lin HP; Li YP; Chen SJ; Fu YC; Xu WC; Wei CJ Gen Comp Endocrinol; 2016 Oct; 237():98-108. PubMed ID: 27570060 [TBL] [Abstract][Full Text] [Related]
14. Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A. Li G; Deng X; Wu C; Zhou Q; Chen L; Shi Y; Huang H; Zhou N J Biol Chem; 2011 Sep; 286(36):31199-212. PubMed ID: 21768093 [TBL] [Abstract][Full Text] [Related]
15. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A. Li YJ; Chen X; Kwan TK; Loh YW; Singer J; Liu Y; Ma J; Tan J; Macia L; Mackay CR; Chadban SJ; Wu H J Am Soc Nephrol; 2020 Jun; 31(6):1267-1281. PubMed ID: 32358041 [TBL] [Abstract][Full Text] [Related]
17. GPR109A Expression in the Murine Min6 Pancreatic Beta Cell Line, and Its Relation with Glucose Metabolism and Inflammation. Yang S; Li X; Wang N; Yin G; Ma S; Fu Y; Wei C; Chen Y; Xu W Ann Clin Lab Sci; 2015; 45(3):315-22. PubMed ID: 26116596 [TBL] [Abstract][Full Text] [Related]
18. Niacin/β-hydroxybutyrate regulates milk fat and milk protein synthesis Chen J; Lin T; Zhang S; Yue X; Liu X; Wu C; Liang Y; Zeng X; Ren M; Chen F; Guan W; Zhang S Food Funct; 2023 Mar; 14(6):2642-2656. PubMed ID: 36866679 [TBL] [Abstract][Full Text] [Related]
19. Nicotinic Acid Receptor GPR109A Exerts Anti-Inflammatory Effects Through Inhibiting the Akt/mTOR Signaling Pathway in MIN6 Pancreatic β cells. Li Z; Li X; Lin S; Chen Y; Ma S; Fu Y; Wei C; Xu W Ann Clin Lab Sci; 2017 Nov; 47(6):729-737. PubMed ID: 29263047 [TBL] [Abstract][Full Text] [Related]
20. Involvement of the Niacin Receptor GPR109a in the LocalControl of Glucose Uptake in Small Intestine of Type 2Diabetic Mice. Wong TP; Chan LK; Leung PS Nutrients; 2015 Sep; 7(9):7543-61. PubMed ID: 26371038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]